Literature DB >> 11161611

Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat.

C Dubé1, S Boyet, C Marescaux, A Nehlig.   

Abstract

The lithium-pilocarpine (Li-Pilo) model of epilepsy reproduces most of the features of human temporal lobe epilepsy. After having studied the metabolic changes occurring during the silent phase, in the present study, we explored the relationship between interictal metabolic changes and neuronal loss during the chronic phase following status epilepticus (SE) induced by Li-Pilo in 10-day-old (P10), 21-day-old (P21), and adult rats. Rats were observed and their EEG was recorded to detect the occurrence of spontaneous recurrent seizures (SRS). Local cerebral glucose utilization was measured during the interictal period of the chronic phase, between 2 and 7 months after SE, by the [(14)C]2-deoxyglucose method in rats subjected to SE at P10, P21, or as adults. Neuronal damage was assessed by cell counting on adjacent cresyl violet stained sections. When SE was induced at P10, rats did not become epileptic, did not develop lesions and cerebral glucose utilization was in the normal range 7 months later. When SE was induced in adult rats, they all became epileptic after a mean duration of 25 days and developed lesions in the forebrain limbic areas, which were hypometabolic during the interictal period of the chronic phase, 2 months after SE. When SE was induced in P21 rats, 24% developed SRS, and in 43% seizures could be triggered (TS) by handling, after a mean delay of 74 days in both cases. The remaining 33% did not become epileptic (NS). The three groups of P21 rats developed quite comparable lesions mainly in the hilus of the dentate gyrus, lateral thalamus, and entorhinal cortex; at 6 months after SE, the forebrain was hypometabolic in NS and TS rats while it was normo- to slightly hypermetabolic in SRS rats. These data show that interictal metabolic changes are age-dependent. Moreover, there is no obvious correlation, in this model, between interictal hypometabolism and neuronal loss, as reported previously in human temporal lobe epilepsy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161611     DOI: 10.1006/exnr.2000.7561

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  38 in total

1.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

2.  Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus.

Authors:  Vanessa Gass da Silveira; Giana de Paula Cognato; Alexandre Pastoris Müller; Fabrício Figueiró; Carla Denise Bonan; Marcos L Santos Perry; Ana Maria Oliveira Battastini
Journal:  Metab Brain Dis       Date:  2010-05-05       Impact factor: 3.584

3.  Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.

Authors:  Tanya McDonald; Mark P Hodson; Ilya Bederman; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

Review 4.  Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.

Authors:  Mussie Ghezu Hadera; Tanya McDonald; Olav B Smeland; Tore W Meisingset; Haytham Eloqayli; Saied Jaradat; Karin Borges; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2015-10-03       Impact factor: 3.996

5.  Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy.

Authors:  Silje Alvestad; Janniche Hammer; Elvar Eyjolfsson; Hong Qu; Ole Petter Ottersen; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

Review 6.  Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.

Authors:  Annamaria Vezzani; Rosaria Pascente; Teresa Ravizza
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

7.  Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Olav B Smeland; Mussie G Hadera; Tanya S McDonald; Ursula Sonnewald; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

8.  Methyl ethyl ketone blocks status epilepticus induced by lithium-pilocarpine in rats.

Authors:  Osamu Inoue; Eriko Sugiyama; Nobuyoshi Hasebe; Noriko Tsuchiya; Rie Hosoi; Masatoshi Yamaguchi; Kohji Abe; Antony Gee
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

9.  Protective effects of curcumin against lithium-pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats.

Authors:  Mohammad Ahmad
Journal:  Saudi J Biol Sci       Date:  2013-01-17       Impact factor: 4.219

Review 10.  Neurogenesis and epilepsy in the developing brain.

Authors:  Brenda E Porter
Journal:  Epilepsia       Date:  2008-06       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.